CTOs on the Move


 
Classy is the world`s largest fundraising platform for social good organizations. We enable nonprofits and social enterprises to raise the support they need to solve humanity`s greatest challenges. We started Classy to mobilize our friends around local causes that we cared about. Now, any social good organization can use the Classy platform empower their supporters to raise money and rally support around a cause. Since 2011, we`ve enabled 1.3 million people across 300K individual campaigns to raise over $130M for social good organizations. From cutting edge health programs to educational advancement, our customers are tackling the world`s greatest challenges with ...
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.classy.org
  • 533 F St Ste 300
    San Diego, CA USA 92101
  • Phone: 619.961.1892

Executives

Name Title Contact Details
Corey Hall
Director of Information Security and Platform Operations Profile

Funding

Classy raised $30M on 11/02/2016
Classy raised $118M on 04/20/2021

Similar Companies

Action Against Hunger-USA

Action Against Hunger-USA is a New York, NY-based company in the Non-Profit sector.

Red Cross- Alabama

Red Cross- Alabama is a Andalusia, AL-based company in the Non-profit sector.

LCMS Foundation

LCMS Foundation is a Saint Louis, MO-based company in the Non-profit sector.

patrick foundation

patrick foundation is a Ridgefield, CT-based company in the Non-profit sector.

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world`s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $615 million and provided funding to more than 2,000 research programs at nearly 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer.